Recent Development News: Q4 – 2015

Cerecor Inc. Names Uli Hacksell, Chairman of Cerecor and Former CEO of ACADIA, as President and CEO

Cerecor Inc. (CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Dr. Blake Paterson will step … Continue reading

Posted in Recent Development News: Q4 - 2015, Recent Developments | Comments Off

Medgenics Announces Beta Thalassemia Research Program

Medgenics, Inc. (NYSE MKT:MDGN), today announced the initiation of a research program to evaluate the use of TARGTEPOTM alone or in combination with iron restriction to ameliorate erythropoiesis in Beta Thalassemia Intermedia (non-transfusion dependent thalassemia or NTDT) and Beta Thalassemia … Continue reading

Posted in Recent Development News: Q4 - 2015, Recent Developments | Comments Off

ContraFect Corporation Concludes Phase 1 Study of CF-301

ContraFect Corporation (CFRX) (CFRXW), a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant infectious diseases, today announced the Phase 1, first-in-human study of CF-301 has concluded. As specified in the … Continue reading

Posted in Recent Development News: Q4 - 2015, Recent Developments | Comments Off

RestorGenex and Diffusionon Pharmaceuticals Announce Merger Agreement

BUFFALO GROVE, Ill. and CHARLOTTESVILLE, Va., Dec. 15, 2015 (GLOBE NEWSWIRE) — RestorGenex Corporation (RESX) and Diffusion Pharmaceuticals LLC, a privately-held biotechnology company, announced today that they have entered into a definitive merger agreement under which a newly formed subsidiary … Continue reading

Posted in Recent Development News: Q4 - 2015, Recent Developments | Comments Off

X4 Pharmaceuticals Unveils Development Strategy for CXCR4 Inhibitor Pipeline in Cancer Supported by $37.5 million Series A Financing

Company to advance multiple CXCR4 programs focused on cancer immunotherapy, including advancing lead candidate X4P­001 into two clinical studies in refractory cancers December 14, 2015 07:00 AM Eastern Standard Time CAMBRIDGE, Mass.­­(BUSINESS WIRE)­­X4 Pharmaceuticals today announced the launch of the … Continue reading

Posted in Recent Development News: Q4 - 2015, Recent Developments | Comments Off

Edge Therapeutics Now Covered by Leerink Swann (EDGE)

Leerink Swann initiated coverage on shares of Edge Therapeutics (NASDAQ:EDGE) in a report published on Monday, The Fly reports. The firm issued an outperform rating and a $27.00 price target on the stock. Separately, Credit Suisse began coverage on shares … Continue reading

Posted in Recent Development News: Q4 - 2015, Recent Developments | Comments Off

Guggenheim Has Started Edge Therapeutics (NASDAQ:EDGE) Stock Coverage With a “Buy” Rating and Target of $30.00

Edge Therapeutics (NASDAQ:EDGE) Price Target & New Coverage by Guggenheim Expert analysts at Guggenheim has initiated coverage on shares of Edge Therapeutics (NASDAQ:EDGE) in a note sent to clients and investors on 26 October. The financial firm set “Buy” rating … Continue reading

Posted in Recent Development News: Q4 - 2015, Recent Developments | Comments Off

Former intel officials take new approach to cyber-defense

COLORADO SPRINGS — The revelation this week that hackers broke into the personal e-mail accounts of two of the nation’s top national security officials has put new focus on the importance of cyber security. CBS correspondent Mark Strassmann reports that … Continue reading

Posted in Recent Development News: Q4 - 2015, Recent Developments | Comments Off

SMS Masterminds, Publicly Traded as SpendSmart Networks, Inc., Announces 5,000,000 Subscriber Milestone

SAN LUIS OBISPO, CA–(Marketwired – Oct 22, 2015) – SpendSmart Networks, Inc. (OTCQB: SSPC) dba “SMS Masterminds,” a national full-service provider of mobile and loyalty marketing solutions, reported that 5,000,000 people have subscribed to its loyalty platform through its network … Continue reading

Posted in Recent Development News: Q4 - 2015, Recent Developments | Comments Off